Skip to main content

Advertisement

SpringerLink
Log in

Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis

  • Notes
  • Ciprofloxacin: Clinical Experience
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wise, R., Andrews, J. M., Edwards, L. J. V.: In vitro activity of BAY O 9867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 559–564.

    PubMed  Google Scholar 

  2. Crump, B., Wise, R., Dent, J.: Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrobial Agents and Chemotherapy 1983, 24: 784–786.

    PubMed  Google Scholar 

  3. Muytjens, H. L., van der Ros-van de Repel, J., van Veldhuizen, G.: Comparative activities of ciprofloxacin, norfloxacin, pipemidic acid and nalidixic acid. Antimicrobial Agents and Chemotherapy 1983, 24: 302–304.

    PubMed  Google Scholar 

  4. Fass, R. J.: In vitro activity of ciprofloxacin (BAY O 9867). Antimicrobial Agents and Chemotherapy 1983, 24: 568–574.

    PubMed  Google Scholar 

  5. Bauernfeind, A., Petermuller, C.: In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. European Journal of Clinical Microbiology 1983, 2: 111–115.

    Article  PubMed  Google Scholar 

  6. Roy, C., Foz, A., Segura, C., Tirado, M., Teixell, M., Teruel, D.: Activity of ciprofloxacin (BAY o 9867) againstPseudomonas aeruginosa and ampicillin-resistantEnterobacteriaceae. Infection 1983, 11: 326–328.

    Article  PubMed  Google Scholar 

  7. Zeiler, H., Grohe, K.: The in vitro and in vivo activity of ciprofloxacin. European Journal of Clinical Microbiology 1984, 3: 339–343.

    PubMed  Google Scholar 

  8. Van Poppel, H., Wegge, M.:Pseudomonas infections in multiple sclerosis. A. Van Leeuwenhoek Journal of Microbiology 1984, 50: 293–295.

    Google Scholar 

  9. Leruitte, A.: Approche microbiologique des infections urinaires àPseudomonas aeruginosa. Acta Urologica Belgica 1979, 47: 683–701.

    PubMed  Google Scholar 

  10. Van Poppel, H., Vereecken, R., Leruitte, A.: Neuromuscular dysfunction of the lower urinary tract in multiple sclerosis. Paraplegia 1983, 21: 374–379.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology and Microbiology, National Institute for Multiple Sclerosis, Van Heylenstraat 16, 1910, Melsbroek, Belgium

    H. Van Poppel, M. Wegge, H. Dammekens & V. Chysky

Authors
  1. H. Van Poppel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Wegge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Dammekens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Chysky
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Poppel, H., Wegge, M., Dammekens, H. et al. Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis. Eur. J, Clin. Microbiol. 5, 251–253 (1986). https://doi.org/10.1007/BF02014002

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02014002

Keywords

Search

Navigation